Genzymes CSR Dilemma: How to Play its HAND Harvard Case Solution & Analysis

Genzyme, a global biotechnology company, is launching a program to develop therapies for neglected diseases (such as malaria, tuberculosis), giving intellectual property. This event aims to address a disease that partnership, and which markets have decided to fund management. But a more serious problem, as the program is developed in the framework of corporate social responsibility umbrella Genzyme role fits into the global competitive strategy. "Hide
by Christopher A. Bartlett, Tarun Khanna, Prithwiraj Chowdhury Source: Harvard Business School 23 pages. Publication Date: August 20, 2009. Prod. #: 910407-PDF-ENG

Share This

SALE SALE

Save Up To

30%

IN ONLINE CASE STUDY

FOR FREE CASES AND PROJECTS INCLUDING EXCITING DEALS PLEASE REGISTER YOURSELF !!

Register now and save up to 30%.